P264 Efficacy and safety of mirikizumab as induction and maintenance treatment in ≥60-year-old adults with moderately-to-severely active ulcerative colitis
Year: 2025
Type: conference-abstract
Source: Gut
Institutions: German Red Cross, DRK Kliniken Berlin, University of Hull, NYU Langone Health, IRCCS Humanitas Research Hospital, Inserm, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand, Örebro University, Universitätsmedizin Greifswald, Universität Greifswald, Technische Universität Dresden, Massachusetts General Hospital, Eli Lilly (United States), University of Toyama
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411553384